Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E F Smit

Showing results (81-90 of 185) with videos related to

Pageof 19
Sort By:
British Journal of Cancer|March 10, 1999
DNA topoisomerase IIalpha and -beta expression in human ovarian cancerS Withoff, A G van der Zee, S de Jong, et al.
Lung Cancer (Amsterdam, Netherlands)|April 29, 2014
Incidence of T790M mutation in (sequential) rebiopsies in EGFR-mutated NSCLC-patientsJ L Kuiper, D A M Heideman, E Thunnissen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1995
Teniposide for brain metastases of small-cell lung cancer: a phase II study. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative GroupP E Postmus, E F Smit, H Haaxma-Reiche, et al.
Lung Cancer (Amsterdam, Netherlands)|May 24, 2014
Metabolic activity measured by FDG PET predicts pathological response in locally advanced superior sulcus NSCLCI Bahce, C G Vos, C Dickhoff, et al.
British Journal of Cancer|December 15, 2004
A randomised phase II trial of docetaxel vs docetaxel and irinotecan in patients with stage IIIb-IV non-small-cell lung cancer who failed first-line treatmentF M Wachters, H J M Groen, B Biesma, et al.
International Journal of Cancer|November 14, 1997
Mechanisms for high methoxymorpholino doxorubicin cytotoxicity in doxorubicin-resistant tumor cell linesM Bakker, J Renes, A Groenhuijzen, et al.
Thorax|January 4, 2003
Prospective use of serial questionnaires to evaluate the therapeutic efficacy of 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) in suspected lung cancerG J Herder, H Van Tinteren, E F Comans, et al.
Lung Cancer (Amsterdam, Netherlands)|October 15, 2011
SUVmax during 18FDG-PET scanning in small cell lung cancer: similar information as in non-small cell lung cancer?C van der Leest, E F Smit, J Baas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2001
Single-agent gemcitabine in patients with resistant small-cell lung cancerI van der Lee, E F Smit, J W van Putten, et al.
European Journal of Cancer (Oxford, England : 1990)|April 9, 2002
A phase II EORTC study of temozolomide in patients with malignant pleural mesotheliomaJ P van Meerbeeck, P Baas, C Debruyne, et al.
Pageof 19

Showing results (81-90 of 185) with videos related to

Sort By:
Pageof 19
British Journal of Cancer|March 10, 1999
DNA topoisomerase IIalpha and -beta expression in human ovarian cancerS Withoff, A G van der Zee, S de Jong, et al.
Lung Cancer (Amsterdam, Netherlands)|April 29, 2014
Incidence of T790M mutation in (sequential) rebiopsies in EGFR-mutated NSCLC-patientsJ L Kuiper, D A M Heideman, E Thunnissen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1995
Teniposide for brain metastases of small-cell lung cancer: a phase II study. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative GroupP E Postmus, E F Smit, H Haaxma-Reiche, et al.
Lung Cancer (Amsterdam, Netherlands)|May 24, 2014
Metabolic activity measured by FDG PET predicts pathological response in locally advanced superior sulcus NSCLCI Bahce, C G Vos, C Dickhoff, et al.
British Journal of Cancer|December 15, 2004
A randomised phase II trial of docetaxel vs docetaxel and irinotecan in patients with stage IIIb-IV non-small-cell lung cancer who failed first-line treatmentF M Wachters, H J M Groen, B Biesma, et al.
International Journal of Cancer|November 14, 1997
Mechanisms for high methoxymorpholino doxorubicin cytotoxicity in doxorubicin-resistant tumor cell linesM Bakker, J Renes, A Groenhuijzen, et al.
Thorax|January 4, 2003
Prospective use of serial questionnaires to evaluate the therapeutic efficacy of 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) in suspected lung cancerG J Herder, H Van Tinteren, E F Comans, et al.
Lung Cancer (Amsterdam, Netherlands)|October 15, 2011
SUVmax during 18FDG-PET scanning in small cell lung cancer: similar information as in non-small cell lung cancer?C van der Leest, E F Smit, J Baas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2001
Single-agent gemcitabine in patients with resistant small-cell lung cancerI van der Lee, E F Smit, J W van Putten, et al.
European Journal of Cancer (Oxford, England : 1990)|April 9, 2002
A phase II EORTC study of temozolomide in patients with malignant pleural mesotheliomaJ P van Meerbeeck, P Baas, C Debruyne, et al.
Pageof 19